Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, IGM Biosciences Inc’s stock clocked out at $6.20, down -8.82% from its previous closing price of $6.80. In other words, the price has decreased by -$8.82 from its previous closing price. On the day, 0.15 million shares were traded. IGMS stock price reached its highest trading level at $6.81 during the session, while it also had its lowest trading level at $6.17.
Ratios:
To gain a deeper understanding of IGMS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.22 and its Current Ratio is at 5.22. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on December 06, 2024, initiated with a Outperform rating and assigned the stock a target price of $21.
On October 01, 2024, Truist Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $24 to $12.
JP Morgan Downgraded its Neutral to Underweight on October 01, 2024, whereas the target price for the stock was revised from $12 to $9.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 16 ’24 when Weber Steven sold 539 shares for $7.48 per share. The transaction valued at 4,032 led to the insider holds 31,704 shares of the business.
Decker Lisa Lynn sold 1,063 shares of IGMS for $7,951 on Dec 16 ’24. The CHIEF BUSINESS OFFICER now owns 78,041 shares after completing the transaction at $7.48 per share. On Dec 16 ’24, another insider, Harler Mary Beth, who serves as the Chief Executive Officer of the company, sold 1,708 shares for $7.48 each. As a result, the insider received 12,776 and left with 347,032 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGMS now has a Market Capitalization of 368678016 and an Enterprise Value of 195747920. For the stock, the TTM Price-to-Sale (P/S) ratio is 126.26 while its Price-to-Book (P/B) ratio in mrq is 4.67. Its current Enterprise Value per Revenue stands at 67.083 whereas that against EBITDA is -0.874.
Stock Price History:
Over the past 52 weeks, IGMS has reached a high of $22.50, while it has fallen to a 52-week low of $5.79. The 50-Day Moving Average of the stock is -38.21%, while the 200-Day Moving Average is calculated to be -40.07%.
Shares Statistics:
It appears that IGMS traded 230.22K shares on average per day over the past three months and 241570 shares per day over the past ten days. A total of 34.06M shares are outstanding, with a floating share count of 17.59M. Insiders hold about 70.41% of the company’s shares, while institutions hold 30.68% stake in the company. Shares short for IGMS as of 1734048000 were 2636887 with a Short Ratio of 11.45, compared to 1731628800 on 2843445. Therefore, it implies a Short% of Shares Outstanding of 2636887 and a Short% of Float of 17.330000000000002.
